Strongly positive MTA1 staining was detected predominantly in the border of necrotic tumor regions and tumor periphery after TACE treatment, compared with most of extensively weak expression before TACE treatment (Figure 3(a)). This evidence concerns the gene MTA1 and neoplasm.